IRLAB Therapeutics AB (publ) (FRA:6IRA)

IRLAB Therapeutics AB Balance Sheet

Financials in millions SEK. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	110.13	66.92	111.31	252.78	401.9	277.01
Cash & Short-Term Investments	110.13	66.92	111.31	252.78	401.9	277.01
Cash Growth	21.85%	-39.88%	-55.96%	-37.10%	45.08%	150.63%
Accounts Receivable	7.04	-	-	3.32	4.47	-
Other Receivables	-	10.08	9.17	8.9	6.27	4.71
Receivables	7.04	10.08	9.17	12.22	10.74	4.71
Prepaid Expenses	-	2.2	2.8	3.34	2.28	2.02
Other Current Assets	-	0.37	0.31	0.35	6.52	0
Total Current Assets	117.17	79.56	123.59	268.68	421.44	283.74
Property, Plant & Equipment	6.52	9.79	6.67	8.01	8.35	4.32
Other Intangible Assets	46.86	46.86	46.86	46.86	42.4	81.49
Long-Term Deferred Charges	-	-	-	-	0.26	0.52
Other Long-Term Assets	0	-0	-	-0	-0	-
Total Assets	170.55	136.21	177.12	323.56	472.45	370.07
Accounts Payable	-	9.94	10.52	10.03	12.3	3.68
Accrued Expenses	-	11.68	14.91	13.44	5.84	11.81
Short-Term Debt	-	53.47	-	-	-	-
Current Portion of Leases	3.48	3.42	2.94	3.6	3.03	1.66
Current Unearned Revenue	-	-	-	-	42.58	-
Other Current Liabilities	86.53	21.54	8.35	5.28	5.65	3.77
Total Current Liabilities	90.01	100.04	36.73	32.34	69.4	20.92
Long-Term Debt	25.42	-	24.51	-	-	-
Long-Term Leases	0.91	3.54	0.12	0.38	3.57	1.27
Total Liabilities	116.34	103.58	61.36	32.72	72.97	22.19
Common Stock	1.7	1.04	1.04	1.04	1.04	0.97
Additional Paid-In Capital	800.41	690.21	690.21	690.21	685.45	685.63
Retained Earnings	-747.9	-658.61	-575.48	-400.41	-287	-338.79
Comprehensive Income & Other	-	0	-	-	-	0.07
Total Common Equity	54.21	32.64	115.76	290.83	399.48	347.88
Shareholders' Equity	54.21	32.64	115.76	290.83	399.48	347.88
Total Liabilities & Equity	170.55	136.21	177.12	323.56	472.45	370.07
Total Debt	29.81	60.42	27.57	3.98	6.6	2.93
Net Cash (Debt)	80.33	6.5	83.74	248.8	395.3	274.08
Net Cash Growth	166.91%	-92.24%	-66.34%	-37.06%	44.23%	158.61%
Net Cash Per Share	1.37	0.13	1.61	4.80	7.64	5.75
Filing Date Shares Outstanding	84.94	51.87	51.87	51.87	51.75	51.75
Total Common Shares Outstanding	84.94	51.87	51.87	51.87	51.75	51.75
Working Capital	27.16	-20.48	86.86	236.34	352.04	262.82
Book Value Per Share	0.64	0.63	2.23	5.61	7.72	6.72
Tangible Book Value	7.35	-14.23	68.9	243.97	357.08	266.39
Tangible Book Value Per Share	0.09	-0.27	1.33	4.70	6.90	5.15
Machinery	-	7.02	6.82	6.53	3.65	2.94
Leasehold Improvements	-	0.12	0.12	0.12	0.12	0.12

Source: S&P Global Market Intelligence. Standard template. Financial Sources.